The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.
Recent Blog Post
April, 2024
New Study Reveals Epigenetic Markers for Type 2 Diabetes Complications in Identical Twins
23rd April 2024 – by Aaruthy Suthahar A recent collaborative effort among seven international twin cohorts, including TwinsUK, has yielded...
March, 2024
Celebrating International Women's Day: Stories from Twins and TwinsUK Staff
25th March 2024 – by Aaruthy Suthahar International Women’s Day (IWD) on March 8th is a day to celebrate the...
March, 2024
TwinsUK part of team awarded £20 million to study bowel cancer
7th March 2024 – by TwinsUK and King’s College London TwinsUK will receive part of £20m in funding by Cancer...